Author

Peter Antal-Szalmas 1

1 Department of Laboratory Medicine,University of Debrecen,Debrecen,Hungary

GUT BARRIER FAILURE BIOMARKERS ARE ASSOCIATED WITH POOR DISEASE OUTCOME IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

Tornai Tamás, György Kovács, Zsuzsanna Vitális, István Tornai, Kai Fechner, Dirk Roggenbuck, David Tornai, Gary L. Norman, Gabor Laszlo Veres, Zakera Shums, Péter Orosz, Béla Lombay, Judit Gervain, Gabriella Par, Alajos Pár, Peter L Lakatos, Ferenc Szalay, Peter Antal-Szalmas, Mária Papp

IGA ANTIBODIES AGAINST FILAMENTOUS-ACTIN ARE FREQUENTLY DETECTED IN PATIENTS WITH CIRRHOSIS AND INDICATE A PROGRESSIVE DISEASE COURSE

Tornai Tamás, Boglarka Balogh, Nora Sipeki, Zsuzsanna Vitális, István Tornai, Peter Antal-Szalmas, Gary L. Norman, Tony Bruns, Mária Papp

PRESEPSIN AS A NEW BIOMARKER FOR OLD EXPECTATIONS IN THE DIAGNOSIS AND PROGNOSIS OF BACTERIAL INFECTION IN CIRRHOSIS

Mária Papp, Tornai Tamás, David Tornai, Zsuzsanna Vitális, István Tornai, Peter L Lakatos, Peter Antal-Szalmas

RECONSIDERING THE PROGNOSTIC VALUE OF TRADITIONAL SEROLOGIC ANTIBODIES IN CROHN’S DISEASE – IMMUNOGLOBULIN CLASSES TO TAKE THE CENTRE STAGE

Nora Sipeki, Boglárka Suga, Gary L. Norman, Zakera Shums, Gabor Laszlo Veres, Peter L Lakatos, Peter Antal-Szalmas, Mária Papp

REDISCOVERY OF THE ANTI-PANCREATIC ANTIBODIES AND EVALUATION OF THEIR PROGNOSTIC VALUE IN A PROSPECTIVE CLINICAL COHORT OF CROHN'S PATIENTS: THE IMPORTANCE OF SPECIFIC TARGET ANTIGENS (GP2 AND CUZD1).

Mária Papp, Nora Sipeki, István Ferenc Altorjay, Gary L. Norman, Zakera Shums, Dirk Roggenbuck, Kai Fechner, Peter Antal-Szalmas, Gabor Laszlo Veres, Peter L Lakatos

RISK MATRIX FOR PREDICTION OF DISEASE PROGRESSION IN A REFERRAL COHORT OF PATIENTS WITH CROHN’S DISEASE

Peter L Lakatos, Nora Sipeki, Gary L. Norman, Zakera Shums, Peter Antal-Szalmas, Gabor Laszlo Veres, Mária Papp

SERUM LEVELS OF LECTIN COMPLEMENT PATHWAY MOLECULES DO NOT PRIMARILY DETERMINE THE RISK OF BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS

Ildikó Földi, David Tornai, Tornai Tamás, Zsuzsanna Vitális, István Tornai, Tamas Dinya, Peter Antal-Szalmas, Mária Papp

SOLUBLE CD163 (SCD163) IS A MARKER OF INFECTION IN PATIENTS WITH CIRRHOSIS AND ACUTE DECOMPENSATION AND AN INDEPENDENT PREDICTOR OF THE SHORT-TERM MORTALITY

Tornai Tamás, David Tornai, Zsuzsanna Vitális, István Tornai, Peter Antal-Szalmas, Mária Papp

TARGET-SPECIFIC ANTI-PANCREATIC ANTIBODIES ARE FREQUENT IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND ASSOCIATED WITH POOR DISEASE OUTCOME

Mária Papp, Tornai Tamás, Nora Sipeki, Zsuzsanna Vitális, István Tornai, Kai Fechner, Dirk Roggenbuck, David Tornai, Gary L. Norman, Zakera Shums, Gabor Laszlo Veres, Péter Orosz, Béla Lombay, Judit Gervain, Gabriella Par, Alajos Pár, Peter L Lakatos, Ferenc Szalay, Peter Antal-Szalmas

Item 1 - 9 / 9
1